Kaamar Azijli
Haarlem, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Best supportive care in stage I-III non-small cell lung cancer: survival by reason for curative treatment omission in a real-world study population.
Journal: Translational lung cancer research
Published: March 19, 2026
Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 21, 2024
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.
Journal: Experimental & molecular medicine
Published: March 07, 2016
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 13, 2015
The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer.
Journal: Journal of kidney cancer and VHL
Published: January 01, 2015
The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.
Journal: Cancer chemotherapy and pharmacology
Published: January 31, 2014
MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Journal: Apoptosis : an international journal on programmed cell death
Published: March 05, 2013
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Journal: Journal of cell science
Published: July 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026